{"as_of":"2026-08-07T17:57:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:cf5cb51cae8922616c5381020788ef803a01a5d21abd2e1b8338ccb792d29d97","coverage":[{"denominator":26,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":26,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-06T19:04:40.218304Z","state":"measured"},{"denominator":26,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":26,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-07T06:34:17.273281+00:00","state":"measured"},{"denominator":0,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":0,"source":"paper_references, paper_reference_links","source_observed_at":null,"state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"cited_works","source_observed_at":null,"state":"measured"}],"external_citation_measurements":[],"inbound":[],"links":{"evidence":"/evidence","html":"/paper/2507.06639/citation-record","integrity":"/paper/2507.06639/integrity","json":"/paper/2507.06639/citation-record.json","paper":"/paper/2507.06639"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:39.930323Z","title":"Emerging properties in self-supervised vision transformers","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.930323Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:0ed953f41acedd230a5493deb9430ffb29aa2cb92b9f41a469133ae4cd22fd42","observation_id":"d99eb16b-39be-4093-a492-344dbeb97b82","resolution":{"observed_at":"2026-08-06T19:04:39.930323Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:39.947395Z","title":"Scaling vision transformers to gigapixel images via hierarchical self-supervised learning","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.947395Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:4ba6cd483026ca66bce7752d827e4b2250211aac656466c74f5d2c147a0e643a","observation_id":"a7a9be2b-c920-43c0-8d0a-51da8fa19323","resolution":{"observed_at":"2026-08-06T19:04:39.947395Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:39.957367Z","title":"Towards a general-purpose foundation model for computational pathology","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.957367Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:202c9bef8fa8f14964bc8284c21afb0bbe0aa6cbca3b13cc67aa687ecaa2a18b","observation_id":"98df8463-78d2-418f-a78d-8bcbce0d3706","resolution":{"observed_at":"2026-08-06T19:04:39.957367Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2411.19666","last_updated":"2024-11-29T12:39:57Z","snapshot_observed_at":"2026-08-02T16:14:35.442247Z","submitted_at":"2024-11-29T12:39:57Z","title":"Multimodal Whole Slide Foundation Model for Pathology","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2411.19666","snapshot_observed_at":"2026-08-06T19:04:39.965870Z","title":"Multimodal whole slide foundation model for pathology","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.965870Z"},"links":{"cited_paper":"/paper/2411.19666","citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:e46f5ce7c6b62f40be6c2fc217c8b2404f59a30c2227477fe3fe42139969ee65","observation_id":"f0985bbd-879a-480a-a85d-cf11b325de6c","resolution":{"observed_at":"2026-08-06T19:04:39.965870Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.349893Z","title":"The cptac data portal: a resource for cancer proteomics research","venue":null,"work_id":"aa9f34d6-86bc-4a67-a357-6272a74d05fb","year":2015},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.979770Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:73e933297a9fc0bdcb9bea9980033a80c5e08af152690b51f8d5d6833f80b822","observation_id":"f0c4758d-08c4-4a94-b4d6-a506faa536af","resolution":{"observed_at":"2026-08-06T19:04:41.362100Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.311313Z","title":"Shallow-deep networks: Understanding and mitigating network overthinking","venue":null,"work_id":"9589f6fd-4048-4e4d-bc3d-f3c2b1317da7","year":2019},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:39.989519Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:39135c5c6a7b881cf5d582365a0a1cae1f4d8d55c4c89cb41f9158a8f09ab9d6","observation_id":"d102331c-b2a0-4908-93e6-bb03d19d25d8","resolution":{"observed_at":"2026-08-06T19:04:41.325536Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2209.15589","last_updated":"2022-10-18T21:46:25Z","snapshot_observed_at":"2026-07-06T13:58:18.393526Z","submitted_at":"2022-09-30T17:04:55Z","title":"Where Should I Spend My FLOPS? Efficiency Evaluations of Visual Pre-training Methods","version":4},"cited_work":{"arxiv_id":"2209.15589","doi":null,"metadata_source":"pith","pith_arxiv_id":"2209.15589","snapshot_observed_at":"2026-08-06T19:04:40.609024Z","title":"Where Should I Spend My FLOPS? Efficiency Evaluations of Visual Pre-training Methods","venue":"cs.CV","work_id":"2b7ee519-3fd9-47ed-bc29-108e4310470b","year":2022},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.003619Z"},"links":{"cited_paper":"/paper/2209.15589","citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:23087f25b321bf7ec7c102a1e7da66343e607337bc7437c52afd2aa56b635bdd","observation_id":"a07cb344-bca0-43e4-b216-5abadc35283b","resolution":{"observed_at":"2026-08-06T19:04:40.628339Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.261894Z","title":"Data-efficient and weakly supervised computational pathology on whole-slide images","venue":null,"work_id":"20241491-500c-4bb4-a274-3ea6a4a798fd","year":2021},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.013457Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:33bd72b4c1067bc77d3adcf6384e06654a5df70ce40f2de09d212ae43eec23a5","observation_id":"a7d20446-3cf8-44c5-bd8b-6bfe270441fa","resolution":{"observed_at":"2026-08-06T19:04:41.276427Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.7937/k9/tcia.2018.oblamn27","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.358556Z","title":"The clinical proteomic tumor analysis consortium clear cell renal cell carcinoma collection (cptac-ccrcc) (version 13) [data set]","venue":null,"work_id":"892b7859-2a1e-4179-898a-90defad1fc46","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.020909Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:1c00b244e5132d871844b6e356f3ebc1d0ec3e9bd7aa8725445effe534a82636","observation_id":"daee1de1-7d92-4a1f-b238-0eb75545b6c4","resolution":{"observed_at":"2026-08-06T19:04:40.375345Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":"10.7937/tcia.caem-ys80","metadata_source":"doi_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.318894Z","title":"The clinical proteomic tumor analysis consortium breast invasive carcinoma collection (cptac-brca) (version 1) [data set]","venue":null,"work_id":"f73a433a-898c-49ba-ab94-9279d26d5e44","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.026893Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:f8c5b55419e5c02c5655f1dc751a9f71a30b1ae104f78cdfdabff2d627bacaaa","observation_id":"f0d3b8da-cbba-4e7b-98bb-69e1994aa88e","resolution":{"observed_at":"2026-08-06T19:04:40.334625Z","resolver_source":"doi","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.035294Z","title":"The clinical proteomic tumor analysis consortium colon adenocarcinoma collection (cptac-coad) (version 1) [data set]","venue":null,"work_id":null,"year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.035294Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:fd8956203dc748945027834beb34707acf4189a0fcb801100714c0574831eb93","observation_id":"206b1088-bd79-41a9-8b6e-7c76015e1ec9","resolution":{"observed_at":"2026-08-06T19:04:40.035294Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2304.07193","last_updated":"2024-02-02T10:24:09Z","snapshot_observed_at":"2026-08-06T05:58:29.182448Z","submitted_at":"2023-04-14T15:12:19Z","title":"DINOv2: Learning Robust Visual Features without Supervision","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2304.07193","snapshot_observed_at":"2026-08-06T19:04:40.045181Z","title":"Dinov2: Learning robust visual features without supervision","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.045181Z"},"links":{"cited_paper":"/paper/2304.07193","citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:7ca50cc0cb67bddc1d9c4b1669d696d8a09924fb07a6dbb9b8fa5bf55dbfdaad","observation_id":"053f5df8-836a-4101-8860-a4b543b2cf9b","resolution":{"observed_at":"2026-08-06T19:04:40.045181Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2405.10254","last_updated":"2024-05-22T17:22:32Z","snapshot_observed_at":"2026-07-06T18:15:24.541427Z","submitted_at":"2024-05-16T16:59:12Z","title":"PRISM: A Multi-Modal Generative Foundation Model for Slide-Level Histopathology","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2405.10254","snapshot_observed_at":"2026-08-06T19:04:40.058583Z","title":"Prism: A multi-modal generative foundation model for slide-level histopathology.arXiv preprint arXiv:2405.10254, 2024","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.058583Z"},"links":{"cited_paper":"/paper/2405.10254","citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:062e077f934af14bd553e92f29ad7f797a1a5330d89ccee89a19ecf46357c4af","observation_id":"9b875636-4645-4487-9b34-32a494159984","resolution":{"observed_at":"2026-08-06T19:04:40.058583Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.232468Z","title":"Solving inefficiency of self-supervised representation learning","venue":null,"work_id":"e762b529-6b64-4b85-9f9e-7d913aa46975","year":2021},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.070608Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:ee7e521f0309e208e95eca45bbdc76fd1af6d0403f83aed9ab1dbd03ecea74fa","observation_id":"7f4af207-3dce-4e61-859b-d2302fda2993","resolution":{"observed_at":"2026-08-06T19:04:41.240175Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.079686Z","title":"A pathology foundation model for cancer diagnosis and prognosis prediction","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.079686Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:3c949808f261499a07e93ec7a13bcd3f613882eaabdf0f7fdb969cf2f094bb4c","observation_id":"ca43753d-3c33-4c6d-9eac-b0605927b96c","resolution":{"observed_at":"2026-08-06T19:04:40.079686Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.142624Z","title":"Wright, Ari Robicsek, Brian Piening, Carlo Bifulco, Sheng Wang, and Hoifung Poon","venue":null,"work_id":"798224c8-1a81-4f83-a28b-6d50b0ad1757","year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.092213Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:55c01f0396e6a58b4acfa94eb75c792d3fc624f07c360f636ce27c40704ca303","observation_id":"34c6c7be-9c12-4557-8f95-aee0897dcf7b","resolution":{"observed_at":"2026-08-06T19:04:41.156184Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2408.00380","last_updated":"2024-08-22T05:07:18Z","snapshot_observed_at":"2026-07-06T18:55:28.646100Z","submitted_at":"2024-08-01T08:41:13Z","title":"EXAONEPath 1.0 Patch-level Foundation Model for Pathology","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2408.00380","snapshot_observed_at":"2026-08-06T19:04:40.103616Z","title":"Agreement","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.103616Z"},"links":{"cited_paper":"/paper/2408.00380","citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:c64e9bde0b87693d567b93be3c4224f2f940ad70a5a56caf6f74abce17221614","observation_id":"8a4b13de-1ba7-4081-83a5-8d6a3337da27","resolution":{"observed_at":"2026-08-06T19:04:40.103616Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.104799Z","title":null,"venue":null,"work_id":"a8088b76-c430-4580-b48d-0b9f960e6931","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.115098Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:2d86f0eb8cbd4a2fa5559a343be2383e52ef3a91ee5e597069ef5e7d7a450b5d","observation_id":"2a896da3-11af-4231-83a6-b77c28486e07","resolution":{"observed_at":"2026-08-06T19:04:41.118655Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.059579Z","title":"EXAONEPath","venue":null,"work_id":"05b85f5a-cd83-4290-a834-100b86d4f70b","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.130507Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:b37323434342fda86bfbb87e85235ef345a9315cfbade4458e4e70a57a42fb0d","observation_id":"23fe8ef8-d96a-4106-a805-2037258cbe9b","resolution":{"observed_at":"2026-08-06T19:04:41.073135Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:41.010477Z","title":"Any commercial exploitation of the Model or its derivatives requires a separate commercial license agreement with the Licensor","venue":null,"work_id":"feabc662-948e-442e-8440-ef24199e75b4","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.139340Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:2cd05d87ee6f6950247e1ababd11bcc35a0d2bcfa795563c3e1e81effd063ee1","observation_id":"4131d236-ad06-4b5a-a401-02253c316eae","resolution":{"observed_at":"2026-08-06T19:04:41.026932Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.956028Z","title":"The Licensee acknowledges that this Agreement does not transfer any ownership rights to the Licensee","venue":null,"work_id":"a6522140-d94a-4431-8a0b-7c7fa2944953","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.154349Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:68500d972611ae1020821697015d629f4bf0db5346baccc400ba8587b3994b0e","observation_id":"700944e0-f565-42d8-8349-af7ffb387b0b","resolution":{"observed_at":"2026-08-06T19:04:40.972563Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.911749Z","title":"As-Is” Basis The Model, Derivatives, and Output are provided on an “as-is","venue":null,"work_id":"58a1342b-e462-4ce3-94c6-4c2e234533cc","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.168024Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:7a12078823b230c7583e06782fe60e9b9a3cb5e38208e82e68cc13a85b064319","observation_id":"b7fc2930-dd94-4a00-8d16-f96d6333c1c2","resolution":{"observed_at":"2026-08-06T19:04:40.919646Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.860482Z","title":null,"venue":null,"work_id":"bfc20675-c860-4e39-87a0-736ce3261643","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.180827Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:37ac7edab7ac75cd86a9c0bcdc492443b7a8da6de4fa711f534d6b2b1ffeaf9c","observation_id":"8760bfc4-5398-4af3-b875-022a6c11041e","resolution":{"observed_at":"2026-08-06T19:04:40.879322Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.823110Z","title":"Termination shall be effective immediately upon notice","venue":null,"work_id":"551bf4bb-450a-4d23-9222-ec504b73f82a","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.196271Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:9b4f6863098729151a8a77b613807d756d3f4dd0d639c0721cc91df0a78c87a4","observation_id":"539b95cd-eb52-42a1-b599-26c6a0f711a3","resolution":{"observed_at":"2026-08-06T19:04:40.836338Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.753182Z","title":null,"venue":null,"work_id":"f31ab2cf-c902-4992-b3b5-dff845c03b72","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.205591Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:bab7a384338585c668616d06e8dfcb83ea3ffeff5e82a679fee4bee0b09244ce","observation_id":"1046ddef-0e1a-46eb-9d51-3bf283759a6f","resolution":{"observed_at":"2026-08-06T19:04:40.771728Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-06T19:04:40.714817Z","title":"Any modifications will be effective upon posting the updated Agreement on the Licensor’s website or through other means of communication","venue":null,"work_id":"ab4d562e-d986-4e8e-9f12-dd1cd91ab7ed","year":null},"citing_paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision","version":2},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-06T19:04:40.218304Z"},"links":{"citing_paper":"/paper/2507.06639"},"observation_digest":"sha256:fef2f91fff5a916ff116ad2f13db58b8481291a30c456ed596620cf2e76fb3a1","observation_id":"c8b6c3aa-acaa-4736-8671-6a0ebe8aaeb7","resolution":{"observed_at":"2026-08-06T19:04:40.727414Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-07T06:34:17.273281+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2507.06639","last_updated":"2025-08-14T02:00:46Z","latest_version":2,"primary_category":"cs.CV","snapshot_observed_at":"2026-08-06T18:55:53.045668Z","submitted_at":"2025-07-09T08:09:05Z","title":"EXAONE Path 2.0: Pathology Foundation Model with End-to-End Supervision"},"reference_resolution":{"displayed":26,"state_counts":{"malformed_identifier":0,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":12,"verified_exact":3,"verified_fuzzy":11},"total_outbound_references":26},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-07T06:34:17.273281+00:00","source":"crossref"},{"observed_at":"2026-08-07T06:34:11.927384+00:00","source":"retraction_watch"}],"thesis":"As of 7 August 2026, this Paper Citation Record lists 26 of 26 outbound references and 0 inbound Pith citation observations for arXiv:2507.06639."}